Rare Daily Staff
RTW Charitable Foundation said it has awarded $900,000 in research grants to support six research studies designed to drive transformational progress in genetic therapies
Founded in 2018 as the charitable foundation arm of RTW Investments, the RTW Charitable Foundation funds initiatives and scientific research designed to improve the health of underserved communities. The foundation provides capital, manpower, and logistical support to help scientists advance projects. To date, the organization has awarded more than 20 research grants, totaling more than $3 million in funding.
The research grants totaled $150,000 each. The recipients included Kathrin Meyer, Nationwide Children’s Hospital, Columbus, Ohio; Julie Saba, University of California, San Francisco, San Francisco; Steven Gray, The University of Texas Southwestern, Dallas; Jagdeep Walia, Queen’s University, Kingston, Ontario, Canada; Alan Beggs, Boston Children’s Hospital, Boston; Haiyan Zhou, University College London, London.
“Despite considerable advancements in gene and cell therapies that deliver more targeted and effective treatments for rare diseases, a significant amount of additional research is still required to move these advances out of the lab and safely to patients,” said Juan Carlos López, managing director or research grants for RTW Charitable Foundation. “We believe that each of these studies will help expedite the development of gene therapies for rare and ultrarare diseases, and greatly improve the lives of individuals with unmet medical needs.”
Stay Connected
Sign up for updates straight to your inbox.